21 Nov 2022 07:00 CET

Issuer

Ultimovacs ASA

Oslo, 21 November 2022, Ultimovacs ASA (the "Company") refers to the
announcement published on 16 November 2022 regarding the issuance of new shares
in connection with the Company's employee incentive program.

The share capital increase related to the share issue of 130,700 new shares has
been registered in the Norwegian Register of Business Enterprises, and the
Company's new share capital is NOK 3,439,646.10, divided into 34,396,461 shares,
each with a par value of NOK 0.10.

For further information, please contact:

Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA
Email: je@radforsk.no
Phone: +47 480 96 355

Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507

Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632


Source

Ultimovacs ASA

Provider

Oslo Børs Newspoint

Company Name

ULTIMOVACS

ISIN

NO0010851603

Symbol

ULTI

Market

Oslo Børs